Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2024 (2)
  • 2023 (3)
  • 2022 (4)
  • 2021 (8)

Subject

  • Prescription Drugs (57)
  • Pharmaceuticals/Pharmacists/Physicians (45)
  • Drug Trafficking (43)
  • Diversion Division (42)
  • Synthetic drugs (36)
  • Seizures (Drugs/Property) (29)
  • Task Forces/Task Force Officers (25)
  • Major Law Enforcement Operation (17)
  • Outreach/Drug Prevention (17)
  • Arrests/Convictions - Major (12)
  • OCDETF/Task Force (12)
  • Fake Pills (11)
  • Guilty Plea (8)
  • One Pill Can Kill (7)
  • Prevention/Education - DEA websites GSAD, JTT etc (7)
  • Guns/Weapons (6)
  • Press Conferences (6)
  • Fentanyl Awareness (5)
  • Take Back Day (4)
  • Public and Media Affairs - also see Congressional Affairs (3)
  • Dark Web- Internet Trafficking (2)
  • Gangs (2)
  • Museum and Visitors Center (1)
  • Narcoterrorism (1)
  • Overdose (16)
  • Intelligence Division - Intelligence Products (1)

Drug Name

  • Fentanyl (203)
  • Heroin (47)
  • Cocaine (38)
  • Synthetic Opioids (24)
  • Methamphetamine (23)
  • Oxycodone (14)
  • Marijuana (Cannabis) (5)
  • Benzodiazepines (3)
  • Hydromorphone (3)
  • Ecstasy/MDMA (2)
  • K2/Spice (2)
  • Morphine (2)
  • Ketamine (1)
  • Marijuana Concentrates (1)
  • Methadone (1)
  • Synthetic Bath Salts or Designer Cathinones (1)
  • Opioids (17)

Field Division

  • Washington, DC (15)
  • Dallas (1)
  • New York (1)
Clear All Results
PRESS RELEASE

U.S. Attorney’s Office and DEA Announce Fatal Fentanyl Overdose Task Force

Octubre 28, 2024
Baltimore, Maryland – Erek L. Barron, U.S. Attorney for the District of Maryland and Jarod Forget, Special Agent in Charge of the Drug Enforcement Administration’s (DEA) Washington Division, announced that their agencies have formed the Maryland Fatal Fentanyl Overdose Task Force (“MFFOTF”). The alarming rate of overdoses in Maryland has...
Octubre 28, 2024
PRESS RELEASE

Nassau Doctor Sentenced to Up to 15 Years in Prison for Overprescription of Opioids that Led to Five Deaths

Enero 22, 2024
MINEOLA, N.Y. – Nassau County District Attorney Anne T. Donnelly announced today that a Nassau County doctor has been sentenced to up to 15 years in prison for prescription practices that led to the deaths of five patients between 2016 and 2018. George Blatti, 78, pleaded guilty on October 10...
Enero 22, 2024
PRESS RELEASE

DEA Washington Division Holds Second Annual Family Summit on Fentanyl

Octubre 13, 2023
WASHINGTON, DC – On October 6, the Drug Enforcement Administration (DEA) Washington Division hosted their 2nd Family Summit in support of those who have lost loved ones to fentanyl poisoning in the District of Columbia, Maryland, and Virginia. The Summit was very emotional and educational to all those who attended...
Octubre 13, 2023
PRESS RELEASE

Consent Decree Approved Among the U.S. and Cumberland, M.D. based Pharmacy and Pharmacist

Julio 06, 2023
Baltimore, Maryland - U.S. District Judge Lydia K. Griggsby approved the United States’ consent decree with John A. Beckman, a Cumberland, Maryland based pharmacist, and Beckman’s Greene Street Pharmacy, Inc. (“Beckman’s Pharmacy”), resolving the United States’ civil allegations that Beckman and Beckman’s Pharmacy violated the Controlled Substances Act (“CSA”) in...
Julio 06, 2023
PRESS RELEASE

DEA Washington Division Announces the Seizure of Over 8 Million of Deadly Doses of Fentanyl in 2022

Enero 26, 2023
Washington DC – The Drug Enforcement Administration’s (DEA) Washington Division seized over 8.3 million potentially deadly doses of fentanyl in 2022. The division, which covers the District of Columbia, Maryland and Virginia confiscated nearly 160,000 fake pills containing fentanyl, and more than 250 pounds of fentanyl powder throughout the year...
Enero 26, 2023
PRESS RELEASE

DEA Washington Division Hosts 1st Family Summit to Engage with Families Affected by Fentanyl Poisoning

Noviembre 22, 2022
WASHINGTON, DC – The Drug Enforcement Administration (DEA) hosted regional family summits across the country in support of those who have lost loved ones to fentanyl poisoning. This is the first undertaking of its kind for the DEA field divisions and builds off the momentum of this summer’s Inaugural Family...
Noviembre 22, 2022
PRESS RELEASE

Sovah Health to Pay United States $4.36 Million to Settle Claims of Controlled Substance Act Violations

Junio 08, 2022
ABINGDON, Va. – Sovah Health has agreed to pay the United States $4.36 million to settle claims that the hospital system violated the Controlled Substances Act (CSA) on numerous occasions between 2017 and 2020. As part of the resolution, Sovah Health further agreed to be subject to a period of...
Junio 08, 2022
PRESS RELEASE

DEA Serves Immediate Suspension Order on Northgate Pharmacy in Waldorf, Maryland

Enero 27, 2022
Washington, D.C., - Jarod Forget, Special Agent in Charge of the DEA Washington Division, announced the issuance of an Immediate Suspension Order (ISO) at Northgate Pharmacy, located at 3973 Saint Charles Parkway, Waldorf, Maryland, today. This morning, members of the Drug Enforcement Administration (DEA) Washington Division’s Tactical Diversion Squad, along...
Enero 27, 2022
PRESS RELEASE

Maryland Nurse Practitioner Pleads Guilty to Conspiracy to Distribute and Dispense Oxycodone

Enero 11, 2022
Greenbelt, Md., – Justina Aburime, age 53, of Bowie, Maryland, pleaded guilty today to one count of conspiracy to distribute and dispense oxycodone and one count of distribution and dispensing of oxycodone. The guilty plea was announced by Jarod Forget, Special Agent in Charge of the DEA Washington Division; United...
Enero 11, 2022
PRESS RELEASE

UT Southwestern to Pay $4.5 Million to Resolve Alleged Controlled Substance Act Violations That Permitted Drug Diversion by Staff

Noviembre 30, 2021
Dallas - The University of Texas Southwestern Medical Center has agreed to pay $4.5 million to resolve allegations that its violations of the Controlled Substances Act allowed hospital staff to divert fentanyl and other dangerous drugs from the hospital, announced DEA Dallas Special Agent in Charge, Eduardo A. Chávez. The...
Noviembre 30, 2021
Showing 1 - 10 of 17 results

Paginación

  • Current page 1
  • Página 2
  • Siguiente página ›
  • Última página »

SAMHSA Behavioral Health Treatment Locator

  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster

United States Drug Enforcement Administration

Back
  • Quiénes somos
  • Recursos
Back
  • Sobre la DEA
  • Mission
  • Nuestra historia
  • Divisiones Nacionales
  • DEA Museum
  • Wall of Honor
  • Contáctenos
Back
  • Operational Divisions
Back
  • Submit a Tip
  • Extortion Scam
  • Public Affairs
  • Social Media Directory
Back
  • Illegal Online Pharmacies
  • OD Justice
  • Fentanyl Supply Chain
  • Pill Press Resources
  • Recovery Resources
  • Together for Families
  • Ley de Libertad de Información
  • Publications
  • Galerías Multimedia
  • Programa de Asistencia a Testigos para Víctimas
Back
  • Fee Waiver
Back
  • Human Trafficking Prevention
  • Submit A Tip +
  • Get Updates
  • Scam Alert
    • English
    • Español